5-Aminolevulinic acid	(5-ALA)
Activated partial thromboplastin time tests	(aPTT)
Adenosine triphosphate	(ATP)
Basal cell carcinoma	(BCC)
Baseline or ground state	(S0)
B-cell lymphoma 2	(Bcl-2)
Bcl-2–associated X	(Bax)
Blue light-emitting diode	(BLED)
Blue-light-emitting diode- photodynamic therapy	(BLED-PDT).
Cervical intraepithelial neoplasia	(CIN)
Chitosan	(CHT)
Cholesteryl hemisuccinate	(CHEMS)
Chondroitin sulfate	(CS)
Circulating tumor cells	(CTCs)
Colorectal cancer	(CRC)
Confocal laser scanning microscopy	(CLSM)
Continuous wave	(CW)
Curcumin	(Cur)
Curcumin conjugated silver nanoparticles	(CUR-AgNPs)
Curcumin loaded PLGA nanoparticles	(CUR-PLGA NPs)
Curcumin nanocrystals	(Cur-NCs)
Curcumin nanoparticles	(CUR-NPs)
Curcumin-loaded liposomes	(Lipo-Cur)
Curcumin-nanoemulsion	(CNE)
Curcumin-loaded solid lipid nanoparticles	(Cur-SLNs)
Cutaneous squamous cell carcinoma	(cSCC)
Cyclodextrins	(CDs)
Demethoxycurcumin	(DMC)
Dendrosomal Nano Curcumin	(DNC)
Deoxyadenosine triphosphate	(dATP)
Dichlorodihydrofluorescein diacetate	(DCFH-DA)
Dioleoyl phosphatidylethanolamine	(DOPE)
Dissolved in dimethyl sulfoxide	(DMSO)
Distearoyl phosphoethanolamine	(DSPE)
EGFRvIII overexpressed human glioblastoma cell line	(DKMG/EGFRvIII cells)
Epidermal growth factor	(EGF)
Epidermal growth factor receptor	(EGFR)
European Medicines Agency	(EMA)
Ferric chloride hexahydrate	(FeCl3·6H2O)
Ferrous sulfate heptahydrate	(FeSO4·7H2O)
Fluorescein isothiocyanate	(FITC)
Fluorescence microscopy imaging system	(FMI)
Food and Drug Administration	(FDA)
Fourier-transform infrared spectroscopy	(FTIR)
Glyceraldehydes 3-phosphate dehydrogenase	(GAPDH)
Immunohistochemistry	(IHC)
Indocyanine Green photosensitizer	(ICG)
Laser irradiation in near-infrared	(NIR)
Light emitting diode	(LED)
Liposome nanocarriers curcumin	(LIP-CUR)
Liposomes	(LPs)
Mesoporous silica nanoparticles	(MSNs)
Monoclonal antibody	(MAb)
Monoclonal antibody against EGFRvIII	(A-EGFRvIII-f)
Mouse embryonic fibroblasts	(MEFs)
Multidrug resistance	(MDR)
Multidrug resistance protein 1	(MDR1)
Myeloid cell leukemia 1	(Mcl-1)
Nanocomposite	(NC)
Nanoparticles	(NPs)
Nanoparticle	(NP)
Nanostructured lipid carriers	(NLCs)
Neutral comet assay	(NCA)
Notch receptor blocker human	(DAPT)
Nuclear Factor-Kappa-B	(NF-κB)
Papillomavirus	(HPV)
Polyethylene glycol	(PEG)
PEGylated lipid nanocarriers	(PLN)
P-glycoprotein	(P-gp)
Phosphate buffer saline	(PBS)
Photodynamic inactivation	(PDI)
Photodynamic therapy	(PDT)
Photosensitizer	(PS)
Photothermal therapy	(PTT)
Poly (lactic-co-glycolic acid) nanoparticles	(PLGA NPs)
Poly (ethylene glycol)	(PEG)
Poly (lactic acid)	(PLA)
Poly (lactic-co-glycolic acid)	(PLGA)
Poly (ε-caprolactone)	(PCL)
Poly (ethylene glycol) polymer	(PEG)
Polyoxyethylene(40)stearate	(Myrj52)
Polyvinylpyrrolidone	(PVP)
Pressure ulcers	(PU)
Reactive oxygen species	(ROS)
Scanning electron microscopy	(SEM)
Silver nanoparticles	(AgNPs)
Excited Singlet state	(S1)
Solid lipid nanoparticles	(SLNs)
Squamous cell carcinoma	(SCC)
Tetraethyl orthosilicate	(TEOS)
The half maximal inhibitory concentration	(IC50)
Transforming growth factor beta	(TGF-β)
Tripolyphosphate	(TPP).
Tumor necrosis factor alpha	(TNF-α)
Tumor Nodes Metastasized	(TNM)
Ultraviolet A	(UVA)
Ultraviolet radiation B	(UVB)
Vascular endothelial growth factor	(VEGF)
Viability measurements	(MTT)
Zinc oxide nanoparticles	(ZnONPCS)